These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6993628)

  • 1. The effect of purified lipopolysaccharide on the bactericidal reaction of human serum complement.
    Allen RJ; Scott GK
    J Gen Microbiol; 1980 Mar; 117(1):65-72. PubMed ID: 6993628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum complement requirements for bacterial killing and protoplast lysis of Escherichia coli ML308 225.
    Allen RJ; Scott GK
    J Gen Microbiol; 1981 Mar; 123(1):179-81. PubMed ID: 7033454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum.
    Tomás JM; Ciurana B; Benedí VJ; Juarez A
    J Gen Microbiol; 1988 Apr; 134(4):1009-16. PubMed ID: 3053980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of turkey complement with Escherichia coli isolated from turkeys.
    Ellis MG; Arp LH; Lamont SJ
    Am J Vet Res; 1989 Aug; 50(8):1285-9. PubMed ID: 2675694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum.
    Demonty J; De Graeve J
    Med Microbiol Immunol; 1982; 170(4):265-77. PubMed ID: 7048047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of different lipopolysaccharides on the serum bactericidal reactions of two strains of Escherichia coli.
    Allen RJ; Scott GK
    Infect Immun; 1981 Feb; 31(2):831-2. PubMed ID: 7012024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-mediated killing of Salmonella typhimurium and Escherichia coli mutants which share a different content of major proteins.
    Galdiero F; Sommese L; Capasso C; Galdiero M; Tufano MA
    Microbiologica; 1991 Apr; 14(2):119-30. PubMed ID: 1857264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of 14C label and complement killing of Escherichia coli.
    Wilson BM; Glynn AA
    Immunology; 1975 Mar; 28(3):391-400. PubMed ID: 1092608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.
    Merino S; Camprubí S; Tomás JM
    J Gen Microbiol; 1991 Jul; 137(7):1583-90. PubMed ID: 1955853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a bacteriophage-encoded glycanase enzyme in the generation of lipopolysaccharide O side chain deficient mutants of Escherichia coli O9:K30 and Klebsiella O1:K20: role of O and K antigens in resistance to complement-mediated serum killing.
    McCallum KL; Laakso DH; Whitfield C
    Can J Microbiol; 1989 Nov; 35(11):994-9. PubMed ID: 2482125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of serum bactericidal reaction by lipopolysaccharide.
    Sansano M; Reynard AM; Cunningham RK
    Infect Immun; 1985 Jun; 48(3):759-62. PubMed ID: 4039705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes.
    Heddle RJ; Knop J; Steele EJ; Rowley D
    Immunology; 1975 Jun; 28(6):1061-6. PubMed ID: 1093969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.
    Hill AW; Shears AL; Hibbitt KG
    Immunology; 1978 Jan; 34(1):131-6. PubMed ID: 75177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli.
    Donaldson DM; Roberts RR; Larsen HS; Tew JG
    Infect Immun; 1974 Sep; 10(3):657-66. PubMed ID: 4609906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4.
    Tedesco F; Rottini G; Patriarca P
    J Immunol; 1981 Nov; 127(5):1910-5. PubMed ID: 7028865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.